Cervical cancer kills 6,582 women annually in Bangladesh, where the diagnosis rate is 2-3 times higher than in the U.S. and hosts a mortality rate five times higher. HAEFA has implemented a “See-and-Treat” Cervical Cancer Screening and Treatment Program to reduce these numbers, using a one-stop mobile (digital) colposcopy and thermocoagulation.

• In Kurigram District, HAEFA provided over 1900 women with cervical cancer screenings conducted in Upazila Health Complexes (UHCs). 28 patients were found VIA positive through the initial screening test and referred for further investigation and treatment. One cervical cancer patient received 3 cycle brachytherapie in November, 2022.
• More than 1,480 women were screened in 6 VIA Centers (Sadar Hospital, MCWC, Ramu UHC, Moheshkhali UHC, Chakaria UHC, Pekua UHC) and 6 VIA camps in the respective Upazilas of Cox’s Bazar, including one hard-to-reach Upazila, Moheshkhali, in November. 28 patients were found VIA positive, through the initial VIA screening test and referred for further investigation. 9 colposcopies were performed at Cox’s Bazar Sadar Hospital. 
• Cases that tested positive through the initial VIA screening were referred for further investigation. Our team followed up with the patients and organized a second VIA screening test and colposcopy in Cox’s Bazar Sadar Hospital, where both colposcopy and thermocoagulation were performed. The Cox’s Bazar Project team followed up with previously identified cancer patients and referred them to Chattogram Medical College and the National Institute of Cancer Research & Hospital (NICRH), Mohakhali, Dhaka for further treatment.

• Cervical cancer kills 6,582 women annually in Bangladesh, where the diagnosis rate is 2-3 times higher than in the U.S. and hosts a mortality rate five times higher. HAEFA has implemented a “See-and-Treat” Cervical Cancer Screening and Treatment Program to reduce these numbers, using a one-stop mobile (digital) colposcopy and thermocoagulation.
   

  • In Kurigram District, HAEFA provided over 1900 women with cervical cancer screenings conducted in Upazila Health Complexes (UHCs). 28 patients were found VIA positive through the initial screening test and referred for further investigation and treatment. One cervical cancer patient received 3 cycle brachytherapie in November, 2022.
  • More than 1,480 women were screened in 6 VIA Centers (Sadar Hospital, MCWC, Ramu UHC, Moheshkhali UHC, Chakaria UHC, Pekua UHC) and 6 VIA camps in the respective Upazilas of Cox’s Bazar, including one hard-to-reach Upazila, Moheshkhali, in November. 28 patients were found VIA positive, through the initial VIA screening test and referred for further investigation. 9 colposcopies were performed at Cox’s Bazar Sadar Hospital.
  • Cases that tested positive through the initial VIA screening were referred for further investigation. Our team followed up with the patients and organized a second VIA screening test and colposcopy in Cox’s Bazar Sadar Hospital, where both colposcopy and thermocoagulation were performed. The Cox’s Bazar Project team followed up with previously identified cancer patients and referred them to Chattogram Medical College and the National Institute of Cancer Research & Hospital (NICRH), Mohakhali, Dhaka for further treatment.

• HAEFA members participate in the introduction, exchange of views, and coordination meeting led by Mr. Sheikh Muhammad Moniruzzaman, the newly appointed Director General of the NGO Affairs Bureau of Bangladesh.

HAEFA healthcare workers have provided free medical care and medicine to the Rohingya FDMNs since its establishment in October 2017. In September 2022, more than 5,100 individuals received free medical care including medicines and diagnostic services from HAEFA. In addition to primary healthcare, the major diseases covered are hypertension, diabetes, asthma, malnutrition, pregnancy with complications, tuberculosis, Dengue, etc.

Kutupalong (Camp 1W):

• More than 2,670 patients visited Camp 1W in Kutupalong and received healthcare services.
• 130 laboratory tests were conducted at HAEFA’s semi-automated NCD Pathological Laboratory

Balukhali (Camp 09):

• More than 1,950 patients visited Camp 09 in Balukhali and received healthcare services.
• 170 laboratory tests were conducted at HAEFA’s semi-automated NCD Pathological Laboratory

HAEFA healthcare workers have provided free medical care and medicine to the Rohingya FDMNs since its establishment in October 2017. In August 2022, more than 5,200 individuals received free medical care and diagnostic services from HAEFA. 

Kutupalong (Camp 1W):

• More than 2,650 patients visited Camp 1W in Kutupalong and received healthcare services.
• 119 laboratory tests were conducted at HAEFA’s semi-automated NCD Pathological Laboratory

Balukhali (Camp 09):

• More than 1,880 patients visited Camp 09 in Balukhali and received healthcare services.
• 221 laboratory tests were conducted at HAEFA’s semi-automated NCD Pathological Laboratory

HAEFA healthcare workers have provided free medical care and medicine to the Rohingya FDMNs since its establishment in October 2017. In July 2022, more than 4,600 individuals received free medical care and diagnostic services from HAEFA. 

Kutupalong (Camp 1W):

• More than 2,430 patients visited Camp 1W in Kutupalong and received healthcare services.
• 270 laboratory tests were conducted at HAEFA’s semi-automated NCD Pathological Laboratory

Balukhali (Camp 09):

• More than 1,670 patients visited Camp 09 in Balukhali and received healthcare services.
• 345 laboratory tests were conducted at HAEFA’s semi-automated NCD Pathological Laboratory

FDMN Rohingya Camp at Bhashan Char:

• More than 1,670 patients visited the HAEFA Medical Check-Up and Treatment for FDMN Rohingya Camp at Bhashan Char and received healthcare services.